Reddit Posts
Bullish News for Psychadelic Stocks? "FDA Issues First Draft Guidance on Clinical Trials with Psychedelic Drugs..."
Special Situations for Thursday: $DSS, $ATAI, $MIGI, $BIOL
Special Situations for Thursday: $DSS, $ATAI, $MIGI, $BIOL
Atai stock rises amid restructuring with ~30% job cuts (NASDAQ:ATAI)
Mexican Senator To File Psychedelics Legalization Bill, With U.S. Congressman Backing International Reform Push
What's your opinion on ATAI and other psychedelic medicine companies?
Unlock The Mind - Solving America's Mental Health Crisis with $ATAI (Atai Life Sciences). Full DD on the Psychedelic sector potential. 🍄
Unlock The Mind - Solving America's Mental Health Crisis with $ATAI (Atai Life Sciences) Full DD on the Psychedelic sector potential. 🍄 DD
A Look at "R-Ketamine" Drug Development Ahead of $ATAI's PCN-101 Phase 2a December 2022 Data Readout (Psychedelic Stock)
ATAI Life Sciences what do you guys think?
What is your opinion on small cap biotech stocks like TSHA and ATAI?
ATAI, A Company with a lot of potential for short term and long-term gains.
What’s your favorite Magic Mushroom Penny Stock? A few I’ve been looking into are FTRP, SEEL, CYBN, CMPS, GHRS, ATAI, MNMD.
Cathie Wood makes her first investment in Psychedelics
$IGXT Due Diligence - Not your average biotech play. Dissolvable Oral films with medicine on them, faster onset, compliance, skip first pass digestion (similar to injections).
The Upcoming Psychedelic Sector Opportunity 🍄 (FDA Phase 2b data readout in November 2021)
The Upcoming Psychedelics Sector #ShroomBoom 🍄 (November 2021 FDA Phase 2b Catalyst)
$IGXT Up 43% in the last four trading sessions despite heavy short volume
Update On $IGXT since my last post, up about 41% since.
$IGXT Patient Screening to Resume in IntelGenx’s ‘BUENA’ Montelukast VersaFilm® Phase 2a Clinical Trial in Patients with Mild to Moderate Alzheimer’s Disease.
$IGXT; Pennystock that has turned the corner and gone from R&D to Manufacturing. Oral film Delivery system (Oral films that go directly to bloodstream, Skip first pass digestion). The market hasn't caught onto this company yet..
IntelGenx Receives U.S.$6 Million in Additional Loans from atai Life Sciences and Conditional Approval to Graduate to Toronto Stock Exchange!!!
$ATAI psychedelics getting ready to go apeshit.
IntelgenX officially launches Rizaport in spain!!
Mentions
ATAI. Up 216% yoy, and drugs haven't even hit the market yet. Rescheduling of marijuana likely to help too
Been a while since I researched, but if memory serves CYBN was one of the leaders in FDA trials of LSD for PTSD treatment. I believe they were also pursuing treatment of LSD and other psychedelics for depression. Specifically, people with depression that SSRI's did nothing for. Another company to look into is ATAI. Backed by Peter Thiel. Their model was 1) inorganic growth by acquiring a lot of other psychedelic businesses and 2) pursuing a patent on synthetic psilocybin molecule. Peter Thiel gave a talk a couple years ago at Davos about psychedelics. Right now there's a lot of pie in the sky with psychedelic stocks, but if these businesses can achieve what they're pursuing: gold mine.
ATAI. Up 221% yoy. Weed rescheduling and postitive drug trial results will boost again in 2026
ATAI (up 221% yoy). Weed rescheduling and drug trial progress will boost again
Me thinks ATAI and psych stocks are going to moon again in 2026 (up 195% ytd). Recent ganja rescheduling is another good sign
$CMPS, $ATAI, $CYBN - Psychedelic medicine is the mental health breakthrough the world needs.
97% of my portfolio is VOO but 3% are my fun individual stocks and I will continue to buy psychedelic industry stocks. MNMD, ATAI, CMPS etc
Patented synthetic psilocybin polymorph (unique crystalline structure) going through FDA clinical trials. It's currently in the second Phase 3 trial, the final stage before potential approval. On top of that you have bipartisan support in Congress, RFK Jr publicly advocating for it, and the head of the FDA himself has said we need to be looking into these compounds. Lastly, FIVE of these compounds now have Breakthrough Therapy designation which further accelerated approval and massively raises approval chances. Psychedelic Drugs with FDA Breakthrough Therapy Designation 1. CYB003 (Deuterated Psilocybin analog) - $CYBN (soon to be $HELP) A novel psilocybin-derived compound developed by Cybin for major depressive disorder (MDD). Received Breakthrough Therapy designation from the FDA. Designed to have a faster onset and shorter duration than classic psilocybin. Currently in advanced clinical trials (Phase 3) for MDD. � Wikipedia +1 2. MM120 (LSD-based compound) - $MMED A specially formulated LSD-derived drug being developed by MindMed for generalized anxiety disorder (GAD). Granted Breakthrough Therapy status based on promising clinical data. � Forbes 3. Psilocybin (COMP360; various formulations) - $CMPS Psilocybin itself has received Breakthrough Therapy designations through specific company programs (e.g., COMPASS Pathways’ COMP360 for treatment-resistant depression and Usona Institute’s psilocybin program for major depressive disorder). These designations date back to earlier in the decade and continue to support ongoing Phase 3 research. � Grass Roots NLP +1 4. 5-MeO-DMT (BPL-003) - $ATAI A novel intranasal formulation of 5-MeO-DMT developed by Atai Life Sciences and Beckley Psytech has recently been reported to receive FDA Breakthrough Therapy designation for treatment-resistant depression. This reflects growing interest in rapid-acting psychedelic treatments beyond psilocybin and LSD. �
Psychedelic medicine should have a massive year, especially if Compass' lead candidate gets FDA approval. $CMPS $ATAI $HELP
All I'm seeing is I should have been smart and loaded up on ATAI on the dip.
$ATAI and $CYBN for short acting clinical psychedelics
Looking for feedback on the following if anyone cares to share their insight. much appreciated AREC QBTS ATAI
EU markets are open.. is everybody sleeping op ATAI? [https://finance.yahoo.com/news/h-c-wainwright-maintains-buy-133916105.html](https://finance.yahoo.com/news/h-c-wainwright-maintains-buy-133916105.html)
Buying back into ATAI over 6 was a fuckin horrible idea.
Yes, with ATAI and MNMD recently. Jumped into those way too early, and was down at least 70% at some points, but walked away with a 25% ROI after a few years.
Parts of it. My IMNM was up. ATAI continues to fall.
ATAI - 60% LYFT - 8% CorMedix - 47% AMAZON - 15% Any feedback?
Throw some on 2027 ATAI calls. Was planning to do the same, and seems like good time to with it being down last few days. Good luck
Anyone know what is happening with ATAI?
ATAI ..thiel is heavily invested , rfk hates ssris ….NIH gave them a multi year grant …so many catalysts
ATAI. Psychedelic medicine is gaining steam and this is the best of the breed. Fast acting, safe and effective therapies are going to go mainstream in the next 5-10 years. Big pharma has only begun to catch on (see J&J's Spravato blockbuster ketamine therapy). Love them or hate them, the current administration is fast-tracking this stuff. Philosophically a very anti-AI investment, but that only boosts my conviction.
gotta yank my $$$ (except ATAI) out to do a house payment. see you guys in 6 months when I can "save" again.
You kidding me?! $MNMD and $ATAI...
I recommend ATAI a few times last week. Up 17% today (plus 6% more after market). You’re welcome.
Whoever downvoted me earlier when I said buy ATAI after they got FDA approved DMT, I hope the wheels on your car fall off
ATAI saved me from POET loss
PCSA PRSO ADAP DVLT CAN ATAI .. all have had some green during these blood bath days. Means ppl have some conviction despite fear
DMT got FDA approval, buy up some ATAI if you’ve met any deemster jesters 🔥
The AH movement on $ATAI is more insane than my EX GF LOLZ
Hell yea, ATAI is below 5$ again!
I think of you every day when I check my investment account and see it up by another $25k. +$600k and counting between ATAI and CMPS
ATAI - Atai Life Sciences Remains Undervalued, Analyst Initiates With Around 125% Stock Upside. Psychedelic treatments! UP over 15% today.
ATAI - Up about 10% today and continues to rise. PT at $12, staying long, bought in at 3.08.
ATAI is saving my portfolio today
BPL-003 has a similar structure and effects as psilocybin and was granted a breakthrough therapy designation (BTD) back in 10/2018. There's a strong possibility that ATAI gets the BTD for BPL-003. BTD's are most likely to occur after completion of phase 2, and ATAI's BPL-003 ended in July 2025. According to corporate updates from ATAI Life Sciences, the company planned to hold an End-of-Phase 2 (EOP2) meeting with the FDA to discuss the BPL-003 program in the third quarter of 2025. As of early October 2025, no official outcome from this meeting has been announced publicly. Key context on the meeting: * **Purpose:** The meeting was to discuss the path forward for Phase 3 trials for BPL-003, a therapy for treatment-resistant depression (TRD). * **Timing:** The meeting was scheduled for the second half of 2025, after atai and Beckley Psytech announced positive Phase 2a and 2b data for BPL-003. * **Potential outcome:** Analysts and investors have discussed the possibility that atai could receive Breakthrough Therapy Designation (BTD) during this time, which would expedite the development process.
This Reddit post is one of the most accurate and well-balanced warnings I’ve seen about small-cap pharma investing — and it aligns with my firsthand experience. That said, it’s also worth noting how fascinating this sector has been over the past six months. The **biotech indices have more than doubled the S&P 500’s last 6 months returns** and even outperformed tech ETFs at times — and the sector just had its **best week in years.** I'm tracking and benefiting from real momentum in areas like **gene therapy**, **RNA therapeutics**, and even some **psychedelic-related neuroscience** plays. Plus many exciting one-product in-development companies are there to be found - if you know the business (few people do). A lot of companies that were absolutely crushed last year and very undervalued at the start of this year have been quietly recovering from the floor — some example names like *Ionis, Arrowhead, Nektar, ATAI, UniQure* have all had solid runs recently, some of course due to new Clinical Trial results (this is NOT a recommendation to buy in now given the price rises these saw - just examples) Of course, there are always the “one great drug” hopefuls and takeover dreams floating around — that’s part of the ecosystem. But what makes biotech so different from “normal” investing is just how unpredictable it is. Even when you know the science, the market reaction can appear irrational if you do not know the bigger picture/dynamics that will not obvious to most retail investors. For me, the safest (and most enjoyable) approach is a **portfolio mindset** — not betting too much on single miracles, but following themes, a bit like Big Pharma does with its pipelines. It’s risky, but fascinating — part science, part psychology. PS I'm ex-Pharma/Biotech and I invest entirely in Biotech - as it's the sector I know, even still - I keep most my initial biotech penny stocks to 1-2% of my portfollio
I keep dipping in and out of ATAI. It's alright, but there are better psilocybin plays out there.
No one talking about ATAI OR BCTX?
HOP on the ATAI train - Theil's next pump
Psychedelic Sector (Right Sector) - MNMD & ATAI (Right Stocks), Most all others wrong stocks in that sector.
ATAI all the way for me.Till deliberation day.
Sold some ATAI for EONR.
ATAI, CURA, PESO, PHIO. Original plays are still being called out. They're just drowning in noise.
IXHL goes down as the day's sole loss. DFLI, NUAI, PHGE, ATAI, and FEIM all performed admirably.
Sold Cap-XX (8% gain) to re-enter ATAI Life Sciences.
Eyeing ATAI Life Sciences. Thiel's backing plus Trump admin support for psychedelics are a powerful duo.
ATAI Life Sciences. US authorities have made positive signals about psychedelics.
In light of all the mental illness-induced violence in this country over the past months, weeks, days, and decade or two... I've been slowly but surely and small-time investing in depression/schizo pharma-shroom stocks and whatnot. Nothing too serious but, I've got sizable stakes in IXHL and ATAI and RVPH.
ATAI just got $11M from the federal gov. Up 300% this year without a drug even on the market yet. Def going to 10x in the next two years. Don't miss out 🍄 https://preview.redd.it/63p2cwpfu3rf1.jpeg?width=1080&format=pjpg&auto=webp&s=76cb96918716018b7979ccbe182122174e8cef25
I'm wondering when BTAI is going to start heading up again, it's gone down a lot from its peak. Don't have anything in it now, but keeping an eye on it since $5 may be possible again if it reverses. Was watching ATAI as well, but missed the pump on it this week. Anyone still feeling optimistic about BTAI?
I would have told you ATAI but it popped off today, might not be a great time to buy, but the price target is still to 2x this year.
ATAI back to 5 then loading up on May leaps
ATAI making groundbreaking advances on depression drug that could alter the market entirely
There's ATAI, theres NRXP, theres many more. I believe in those treatments, but hell, I got burned by many of those.
ATAI 52 week high 🍄 https://preview.redd.it/kgdoogcwixqf1.jpeg?width=1080&format=pjpg&auto=webp&s=19f2be6955c5e2642bce331767efbe49c7023755
ATAI still climbing, good phase 2 drug results released today. It's not too late ... https://preview.redd.it/q0lylyk68xqf1.jpeg?width=1080&format=pjpg&auto=webp&s=13e4d3d5a843bbc60ce7e1934d15b671af748296
ATAI gets positive research results 🚀
ATAI and MNMD have done pretty well YTD. I started that play perfectly last November, but then paper handed both of them during the tariff fiasco in the spring.
I tried to tell yall about ATAI 🤷♂️ https://preview.redd.it/pyutjfcrtqqf1.jpeg?width=1080&format=pjpg&auto=webp&s=b7bf3291bf7b17159885a3ff61952f29a2da24f6
number 1 was SOFI. i first bought around $20, sold when it was around $27 (i think pre-market), and bought back in when it went to $18, thinking i could ride it back up again. i was new to the markets like a lot of people and i really didn't know what i was doing, but as i got to know the company i started to really get "invested" in them. i held over a dozen different stocks, but SOFI earned my highest conviction. i also held onto a few hundred PLTR stocks, but i didn't do more because the classified nature of the majority of their work and technology made it feel like i was just gambling, and when tech really started to fall i wanted to make only intelligent moves that i could justify with the data. i'm still holding 9,000 shares of SOFI at a cost basis of $7.50/share. i'm also holding 15,000 shares of ATAI @ $1.18/share. i had more, but i sold 8,000 shares in order to take advantage of the healthcare sector. and i sold all of my PLTR shares for the same reason. PLTR was up over 1,200%, so to ask for more than that just seemed ridiculous. i think the healthcare stocks will double before PLTR doubles again. so here we are.
Where do we see $ATAI heading?
is ATAI even penny anymore, seems like it's got good momentum and consolidated the mid 4s
I also like ATAI and ONDS. If you have patience and depending on their phase 3 trials CGTX has potential in the next couple years.
The volume on psychedelic stocks is crazy. PSIL ATAI CMPS CYBN are bout to blow
Psychedelic approvals must be coming with this volume ATAI PSIL CMPS CYBN
What's the long term price target of $ATAI? Also, seen 3-5 billion market cap number floated around, but that seems conservative.
I sold 40k shares of ATAI at 1.51 in april. It happens. And the more you look around and the more you buy/sell, the more frequently it happens. And I was happy when I sold since I bought at 1.38 and made 10% in a couple days
Don’t sleep on shroom stocks with all the data coming and the work with RFK’s FDA. CMPS and ATAI lead the pack.
$ATAI to the moon bby.
Continuing to buy psychedelic stocks, per usual. PSIL ATAI CYBN CMPS
Psychedelics approval is all but guaranteed with this administration and you’re going to miss the boat ATAI CYBN CMPS PSIL
Shroom stocks beating the odds today ATAI CYBN CMPS
Fair point but if it had drugs that weren't in the research phase, we wouldn't be talking about this on a penny stocks subreddit - To diversify that risk somewhat, ATAI does have quite a few treatments in their development pipeline (https://atai.com/programs-and-research/pipeline/) As far as policy risk, there have been a lot of statements by the current US administration that signal enthusiasm for psychedelic treatments - I linked a couple in my original post. I think it's likely that psychedelic treatments will face an added level of skepticism due to the history of psychedelics, but I believe there's a political, societal, and medical openness to psychedelic treatments that makes such stringent policy as outlawing psychedelic derived pharmaceuticals unlikely. Maybe if there were significant adverse events during testing, but another highlight of ATAI's BPL-003 phase 2 results is that they reported no serious adverse events - https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-and-beckley-psytech-announce-positive-topline.